Hypaque Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with Hypaque
S
- Saleto-200 (ibuprofen)
- Saleto-400 (ibuprofen)
- Saleto-600 (ibuprofen)
- Saleto-800 (ibuprofen)
- Salflex (salsalate)
- Salofalk (mesalamine)
- salsalate
- Salsitab (salsalate)
- Saluron (hydroflumethiazide)
- Salutensin (hydroflumethiazide / reserpine)
- Salutensin-Demi (hydroflumethiazide / reserpine)
- Sandimmune (cyclosporine)
- Sectral (acebutolol)
- Seglentis (celecoxib / tramadol)
- Segluromet (ertugliflozin / metformin)
- Septopal (gentamicin)
- Ser-Ap-Es (hydralazine / hydrochlorothiazide / reserpine)
- Serathide (hydralazine / hydrochlorothiazide / reserpine)
- Serpazide (hydralazine / hydrochlorothiazide / reserpine)
- Serpex (hydralazine / hydrochlorothiazide / reserpine)
- Sine-Aid IB (ibuprofen / pseudoephedrine)
- Sinus & Cold D (naproxen / pseudoephedrine)
- sirolimus
- Sitavig (acyclovir)
- Soaanz (torsemide)
- Sodium Edecrin (ethacrynic acid)
- sodium iodide i-123
- sodium iodide-i-131
- Sorine (sotalol)
- sotalol
- Sotalol Hydrochloride AF (sotalol)
- Sotylize (sotalol)
- spironolactone
- Sprix (ketorolac)
- streptomycin
- streptozocin
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Sudafed 12 Hour Pressure+Pain (naproxen / pseudoephedrine)
- Sudafed PE Head Congestion + Pain (ibuprofen / phenylephrine)
- Sular (nisoldipine)
- sulfasalazine
- Sulfazine (sulfasalazine)
- sulindac
- Symfi (efavirenz / lamivudine / tenofovir)
- Symfi Lo (efavirenz / lamivudine / tenofovir)
- Symtuza (cobicistat / darunavir / emtricitabine / tenofovir alafenamide)
- Synjardy (empagliflozin / metformin)
- Synjardy XR (empagliflozin / metformin)
More about Hypaque (diatrizoate)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: ionic iodinated contrast media
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.